advertiser banner advertiser banner advertiser banner
Digital Issues

Home >  E-Weekly >  June 24, 2014

Do Hospital Readmissions Tell the Whole Story?

Published: June 23, 2014

Medicare's use of administrative claims data is an unfair way to identify hospitals with unusually high readmission rates following surgical procedures, according to a new study in JAMA Surgery.

Researchers reviewed 315 consecutive patients discharged following general surgery procedures over a 2-year period. They compared the reasons for readmission within 30 days of discharge noted in medical records with administrative diagnoses recorded in the medical center's claims database — the information Medicare would review to measure all-cause readmission rates and levy financial penalties on hospitals with rates that were higher than expected.

According to the findings, the reasons for readmission differed between clinical diagnosis and claims data in about one-third of the cases. Additionally, the claims data identified only 5% of readmissions as planned when the medical records indicated nearly 14% were expected. The clinical data also showed about one-fourth of the unplanned readmissions were for reasons unrelated to the original surgeries.

"Administrative billing data, as used by the readmission measure, do not reliably describe the reason for readmission," wrote the researchers.

In an accompanying editorial, David R. Urbach, MD, MSc, of the division of general surgery at the University of Toronto in Canada, points out that at least 8% of surgical patients required re-hospitalization within a month, and wondered how many readmissions are preventable.

"Although discharge interventions can reduce readmission rates, so too can increasing the length of a hospital stay, creating an incentive for hospitals to trade off efficiency to avoid readmission-related penalties," he wrote. "Surgical care is highly nuanced, and surgeons need to be engaged in this process."

Daniel Cook

Have an account? Please log in:
Email Address:
  Remember my login on this computer


advertiser banner

Other Articles That May Interest You

Stryker Subsidiary Distributed Knee-Replacement Cutting Guides Without FDA Approval

Stryker fined $80M for conduct that happened before acquisition.

Hospital Blames EHR for Release of Ebola Patient

His travel history wasn't part of 'physican's workflow.'

FDA Nixes Exparel as Nerve Block

Drug maker Pacira vows to continue its quest.